Envestnet Asset Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $974K | Buy |
29,467
+5,146
| +21% | +$170K | ﹤0.01% | 3295 |
|
|
2025
Q1 | $977K | Sell |
24,321
-2,134
| -8% | -$85.8K | ﹤0.01% | 3224 |
|
|
2024
Q4 | $1.24M | Sell |
26,455
-6,612
| -20% | -$311K | ﹤0.01% | 3013 |
|
|
2024
Q3 | $1.75M | Buy |
33,067
+2,441
| +8% | +$129K | ﹤0.01% | 2757 |
|
|
2024
Q2 | $1.66M | Buy |
30,626
+6,127
| +25% | +$332K | ﹤0.01% | 2707 |
|
|
2024
Q1 | $1.72M | Buy |
24,499
+3,742
| +18% | +$262K | ﹤0.01% | 2675 |
|
|
2023
Q4 | $1.73M | Sell |
20,757
-7,200
| -26% | -$601K | ﹤0.01% | 2565 |
|
|
2023
Q3 | $824K | Buy |
27,957
+7,043
| +34% | +$207K | ﹤0.01% | 2943 |
|
|
2023
Q2 | $682K | Sell |
20,914
-430
| -2% | -$14K | ﹤0.01% | 3037 |
|
|
2023
Q1 | $751K | Buy |
21,344
+72
| +0.3% | +$2.53K | ﹤0.01% | 2871 |
|
|
2022
Q4 | $975K | Sell |
21,272
-2,399
| -10% | -$110K | ﹤0.01% | 2666 |
|
|
2022
Q3 | $1.15M | Sell |
23,671
-365
| -2% | -$17.7K | ﹤0.01% | 2462 |
|
|
2022
Q2 | $944K | Buy |
24,036
+4,202
| +21% | +$165K | ﹤0.01% | 2642 |
|
|
2022
Q1 | $730K | Buy |
19,834
+1,419
| +8% | +$52.2K | ﹤0.01% | 2886 |
|
|
2021
Q4 | $839K | Buy |
18,415
+2,650
| +17% | +$121K | ﹤0.01% | 2738 |
|
|
2021
Q3 | $563K | Sell |
15,765
-4,712
| -23% | -$168K | ﹤0.01% | 2902 |
|
|
2021
Q2 | $405K | Buy |
20,477
+1,680
| +9% | +$33.2K | ﹤0.01% | 3106 |
|
|
2021
Q1 | $437K | Buy |
18,797
+6,900
| +58% | +$160K | ﹤0.01% | 2921 |
|
|
2020
Q4 | $247K | Sell |
11,897
-1,742
| -13% | -$36.2K | ﹤0.01% | 3023 |
|
|
2020
Q3 | $295K | Buy |
13,639
+894
| +7% | +$19.3K | ﹤0.01% | 2739 |
|
|
2020
Q2 | $300K | Sell |
12,745
-7,359
| -37% | -$173K | ﹤0.01% | 2683 |
|
|
2020
Q1 | $237K | Buy |
+20,104
| New | +$237K | ﹤0.01% | 2662 |
|